Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/27/2012US8318728 Compounds and compositions for treating chemical warfare agent-induced injuries
11/27/2012US8318727 Polo-like kinase inhibitors
11/27/2012US8318726 Benzylidineanthracenone linked pyrrolobenzodiazepine hybrids useful as anticancer agents and process for the preparation thereof
11/27/2012US8318725 Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
11/27/2012US8318724 Small molecule inhibitors of MRP1 and other multidrug transporters
11/27/2012US8318723 Pyrazine compounds, their use and methods of preparation
11/27/2012US8318722 Pyrazinooxazepine derivatives
11/27/2012US8318721 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/27/2012US8318720 Acrylamide derivatives as Fab I inhibitors
11/27/2012US8318719 Inhibitors of Bruton's tyrosine kinase
11/27/2012US8318718 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
11/27/2012US8318717 Tetrapeptide capable of inhibiting binding of the Smac protein to Inhibitors of apoptosis, thus promoting apoptosis or sensitizing cells; antiproliferative and anticarcinogenic agents
11/27/2012US8318716 Carbapenem derivatives
11/27/2012US8318715 Methods of treating hypertriglyceridemia
11/27/2012US8318714 Liquid ganaxolone formulations and methods for the making and use thereof
11/27/2012US8318713 Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-A] pyridine-3-yl-2,5-Dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine
11/27/2012US8318712 Concentrated liquid thyroid hormone composition
11/27/2012US8318711 Use of diacetyl trimer as an aromatic and flavouring substance
11/27/2012US8318709 Combination of azelastine and mometasone for nasal administration
11/27/2012US8318708 Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosis
11/27/2012US8318707 Administration of (S)-roscovitine for protection against and/or treatment of neurological diseases
11/27/2012US8318706 Substituted tetracycline compounds
11/27/2012US8318705 Nitroso compounds as nitroxyl donors and methods of use thereof
11/27/2012US8318704 Modulation of neural stem cells and neural progenitor cells
11/27/2012US8318703 Methods for improving kidney function
11/27/2012US8318702 Di(arylamino)aryl compounds
11/27/2012US8318701 Phosphonate analogs of HIV inhibitor compounds
11/27/2012US8318700 Lung-targeted drugs
11/27/2012US8318699 Tumor necrosis factor inhibitors
11/27/2012US8318698 Process for synthesizing silver-silica particles and applications
11/27/2012US8318697 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
11/27/2012US8318696 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
11/27/2012US8318695 Tunably crosslinked polysaccharide compositions
11/27/2012US8318694 Process for producing sugar chain derivative, structure analysis method, and sugar chain derivative
11/27/2012US8318692 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318685 Antibacterial aminoglycoside analogs
11/27/2012US8318684 Antibiotics, bispolides A1, A2, and A3 as well as bispolides B1, B2a, B2b and B3 and processes for producing said antibiotics
11/27/2012US8318683 Anti-cancer therapies
11/27/2012US8318682 1′substituted carba-nucleoside analogs for antiviral treatment
11/27/2012US8318676 Use of agents containing creatine, creatinine and/or their derivatives to fortify and improve the structure of keratinic fibers
11/27/2012US8318672 Cellular factor-containing solution compositions
11/27/2012US8318669 Method of regulating glucose metabolism, and reagents related thereto
11/27/2012US8318665 Cytokine containing compositions
11/27/2012US8318663 Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent
11/27/2012US8318638 Plant activator
11/27/2012US8318467 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
11/27/2012US8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/27/2012US8318422 Antibacterial treatment of osteoarthritis
11/27/2012US8318235 On site polymerization of vinylidenefluoride and hexafluoropropolyene to desired thickness, dip coating stent and/or catheter having complex configuration into latex emulsion containing medication; reducing material loss; customized variable dosaging
11/27/2012US8318221 Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
11/27/2012US8318213 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor
11/27/2012US8318211 Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
11/27/2012US8318202 Stable compositions of famotidine and ibuprofen
11/27/2012US8318201 Method of stabilizing diarylvinylene compound
11/27/2012US8318196 Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations
11/27/2012US8318194 Implants for administering substances and methods of producing mesoporous implants
11/27/2012US8318190 Method of treating disorders using compositions comprising zotarolimus and paclitaxel
11/27/2012US8318188 Medium chain peroxycarboxylic acid compositions
11/27/2012US8318186 Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive
11/27/2012US8318184 MGLU2 agonists
11/27/2012US8318178 Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
11/27/2012US8318177 Viral chemokine-antigen fusion proteins
11/27/2012US8318145 Multi-arm polymer prodrugs
11/27/2012US8318144 As wetting agents and polyquaternium" microbiocides; preferably ethylene oxide-1,2-butylene oxide copolymer
11/27/2012US8318140 Methods for promoting hair growth
11/27/2012CA2754237A1 Cyanoquinoline compounds having activity in correcting mutant-cftr processing and increasing ion transport and uses thereof
11/27/2012CA2738861C Photosensitizer composition for treating skin disorders
11/27/2012CA2706571C 5-anilinoimidazopyridines and methods of use
11/27/2012CA2702482C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2702467C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2695742C Bicyclic amides for enhancing glutamatergic synaptic responses
11/27/2012CA2690841C Synthetic bile acid composition, method, and preparation
11/27/2012CA2680292C Intermediates useful for the preparation of n-substituted carbamoyloxyalkyl-azolium derivatives
11/27/2012CA2666612C Methods, compositions, and formulations for the treatment of thyroid eye disease
11/27/2012CA2653664C Phosphine transition metal complex, process for producing same, and anticancer agent
11/27/2012CA2643400C Camptothecin derivatives and their uses
11/27/2012CA2629570C Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
11/27/2012CA2615975C Compositions for reducing the incidence of drug induced arrhythmia
11/27/2012CA2599334C External plaster containing flurbiprofen
11/27/2012CA2598521C Heterocyclylamide-substituted imidazoles
11/27/2012CA2597300C Novel betulinic acid derivatives
11/27/2012CA2586181C Analgesic
11/27/2012CA2577745C Hcv inhibiting bi-cyclic pyrimidines
11/27/2012CA2569016C Fused heterocyclic compound
11/27/2012CA2568725C Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists
11/27/2012CA2567662C Compounds and compositions as protein kinase inhibitors
11/27/2012CA2564542C Combination formulations of anthracycline agents and cytidine analogs
11/27/2012CA2563946C Food compositions containing creatine
11/27/2012CA2563440C Orally disintegrating tablets and methods of manufacture
11/27/2012CA2561944C Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists
11/27/2012CA2558212C Interferon-beta for anti-virus therapy for respiratory diseases
11/27/2012CA2556815C Skincare compositions comprising salicylic acid
11/27/2012CA2555162C Use of n-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury
11/27/2012CA2551324C Heteroaryl-ureas and their use as glucokinase activators
11/27/2012CA2542663C Microemulsions of retinoids, and pharmaceutical compositions containing them
11/27/2012CA2536954C C-kit modulators and methods of use
11/27/2012CA2535932C Enhancement of magnesium uptake in mammals
11/27/2012CA2533377C Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/27/2012CA2531766C Entry inhibitors of the hiv virus
1 ... 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 ... 7860